Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Harpreet Singh
Aug 17, 2024, 09:13 |
Positive
Harpreet Singh: Exciting news in colorectal cancer treatment
Harpreet Singh, Chief Medical Officer at Precision For Medicine, shared a post on LinkedIn: "Exciting…
Aug 3, 2024, 10:13 |
Drugs
Harpreet Singh: ODAC vote marks a pivotal moment in oncology drug development
Harpreet Singh, Chief Medical Officer at Precision For Medicine, shared on LinkedIn: "The recent FDA…
May 24, 2024, 15:17 |
Blog
Harpreet Singh: I am thrilled to join Precision for Medicine as Chief Medical Officer!
Harpreet Singh, Chief Medical Officer at Precision for Medicine, shared a post by Precision for Medicine, on X:…
Apr 28, 2024, 14:39 |
Blog
Harpreet Singh: Join us for what promises to be an exciting and informative workshop on the approach to resectable, early stage tumors
Harpreet Singh, Division Direction at FDA Oncology shared a post by American Association for Cancer…
Jul 29, 2024, 13:24 |
Insight
Gautam Mehta et al. summarize the FDA accelerated approval of fam-trastuzumab deruxtecan-nxki - FDA Oncology
FDA Oncology shared a post on X about a paper titled "FDA approval summary: fam-trastuzumab…
Jul 19, 2024, 22:19 |
Insight
Gautam Mehta summarizes the FDA accelerated approval of fam-trastuzumab deruxtecan-nxki for HER2-mutated NSCLC
FDA oncology shared on X: "OCE's Gautam Mehta and colleagues summarize the FDA accelerated approval…
May 13, 2024, 05:26 |
Blog
AACR - Joint workshop on Trial Designs for Treatment Regimens with Multiple Phases
AACR shared a post on X: "AACR Past President Elizabeth M. Jaffee and FDA oncology's Harpreet…
Apr 20, 2024, 19:03 |
Blog
How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases - FDA Oncology
FDA Oncology shared on X/Twitter: "How Much is Enough? Trial Designs for Treatment Regimens with…
Mar 7, 2024, 01:48 |
Blog
Patrick Hwu: At the 10th Annual Immuno-Oncology 360° Summit, I gave a keynote address on the Future of TIL Therapy this morning!
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on X: "Excited to be…
Jan 8, 2024, 09:57 |
Insight
Vivek Subbiah: Dr. Timil Patel and colleagues from the FDA Oncology call upon the drug development community to find ways to make clinical trials simpler
Vivek Subbiah shared on X: "Since clinical trials in oncology that are submitted for regulatory…
All:
10
Posts:
1 - 10
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
MASCC24 Highlights: The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Facebook
RSS Feed
Twitter
Linkedin
Youtube